NCT04912232

Brief Summary

This study is Phase 3 of a three-phase DOD CDMRP funded project for the development of a multi-technology poly-anatomic noninvasive system for early detection of occult hemorrhage. Early detection of ongoing hemorrhage (OH) before onset of shock is a universally acknowledged great unmet need, and particularly important after trauma. Delays in the detection of OH are associated with a "failure to rescue" and a dramatic deterioration in prognosis once the onset of clinically frank shock has occurred. An early alert to the presence of OH with an acceptable rate of false-positives and false-negatives would save countless lives. Additionally, such technology would save significant time, money and effort by allowing medical resources to be applied more accurately - the essence of precision medicine. An automated system would monitor currently stable patients continuously, leaving clinicians free to care for patients in need of attention.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2022

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 3, 2021

Completed
1.5 years until next milestone

Study Start

First participant enrolled

December 8, 2022

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2022

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

May 24, 2024

Completed
Last Updated

May 24, 2024

Status Verified

June 1, 2023

Enrollment Period

Same day

First QC Date

May 28, 2021

Results QC Date

June 8, 2023

Last Update Submit

April 29, 2024

Conditions

Keywords

Occult BleedingHemorrhageHemorrhagic ShockTrauma InjuryPrecision MedicineTriageBioimpedanceElectrical Impedance TomographyElectrical Impedance SpectroscopyNear-Infrared Spectroscopy

Outcome Measures

Primary Outcomes (5)

  • Algorithm Performance: Time of Alarm Before Onset of Deterioration

    patient data will be collected over 3-6 hours

  • Algorithm Performance: Sensitivity as Measured by for Alarm/no Alarm Outcome

    patient data will be collected over 3-6 hours

  • Algorithm Performance: Specificity as Measured by for Alarm/no Alarm Outcome

    patient data will be collected over 3-6 hours

  • Algorithm Performance: Positive Predictive Value for Alarm/no Alarm Outcome

    patient data will be collected over 3-6 hours

  • Algorithm Performance: Negative Predictive Value for Alarm/no Alarm Outcome

    patient data will be collected over 3-6 hours

Study Arms (1)

Trauma Patients

EXPERIMENTAL

Patients suffering blunt and/or penetrating trauma but without physiologic criteria suggestive of ongoing hemorrhage: 1. Awake and alert GCS \>14 2. Admission systolic blood pressure greater than 90 and heart rate less than 120 3. Without signs of clinically significant ongoing external hemorrhage with no active bleeding documented on radiology/ultrasound and stable vital signs (no signs of hemodynamic deterioration) during initial evaluation (approximately 15 minutes post admission)

Device: Detection of Occult Hemorrhage in Trauma Patients

Interventions

Non-invasive monitoring of trauma patients

Trauma Patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Awake and alert GCS \>14
  • Admission systolic blood pressure greater than 90 and heart rate less than 120
  • Without signs of clinically significant ongoing external hemorrhage with no active bleeding documented on radiology/ultrasound and stable vital signs (no signs of hemodynamic deterioration) during initial evaluation (approximately 15 minutes post admission)

You may not qualify if:

  • Altered mental status GCS \< 13
  • Systolic blood pressure less than 90 or heart rate greater than 120
  • Need for ongoing fluid or pressor support (standard local fluid resuscitation only)
  • Clinically significant ongoing external hemorrhage
  • Respiratory distress with O2 saturation \<96%
  • Pre-existing systemic illness, likely to alter systemic cardiovascular response to hemorrhage (overt clinical heart failure). Including congestive heart failure, and a paced cardiac rhythm.
  • Pregnant
  • Prisoner status

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baystate Medical Center

Springfield, Massachusetts, 01199, United States

Location

Related Publications (8)

  • Shackelford SA, Colton K, Stansbury LG, Galvagno SM Jr, Anazodo AN, DuBose JJ, Hess JR, Mackenzie CF. Early identification of uncontrolled hemorrhage after trauma: current status and future direction. J Trauma Acute Care Surg. 2014 Sep;77(3 Suppl 2):S222-7. doi: 10.1097/TA.0000000000000198. No abstract available.

    PMID: 24770559BACKGROUND
  • Parks JK, Elliott AC, Gentilello LM, Shafi S. Systemic hypotension is a late marker of shock after trauma: a validation study of Advanced Trauma Life Support principles in a large national sample. Am J Surg. 2006 Dec;192(6):727-31. doi: 10.1016/j.amjsurg.2006.08.034.

    PMID: 17161083BACKGROUND
  • Wo CC, Shoemaker WC, Appel PL, Bishop MH, Kram HB, Hardin E. Unreliability of blood pressure and heart rate to evaluate cardiac output in emergency resuscitation and critical illness. Crit Care Med. 1993 Feb;21(2):218-23. doi: 10.1097/00003246-199302000-00012.

    PMID: 8428472BACKGROUND
  • Convertino VA, Moulton SL, Grudic GZ, Rickards CA, Hinojosa-Laborde C, Gerhardt RT, Blackbourne LH, Ryan KL. Use of advanced machine-learning techniques for noninvasive monitoring of hemorrhage. J Trauma. 2011 Jul;71(1 Suppl):S25-32. doi: 10.1097/TA.0b013e3182211601.

    PMID: 21795890BACKGROUND
  • Convertino VA. Blood pressure measurement for accurate assessment of patient status in emergency medical settings. Aviat Space Environ Med. 2012 Jun;83(6):614-9. doi: 10.3357/asem.3204.2012.

    PMID: 22764618BACKGROUND
  • Kim SH, Lilot M, Sidhu KS, Rinehart J, Yu Z, Canales C, Cannesson M. Accuracy and precision of continuous noninvasive arterial pressure monitoring compared with invasive arterial pressure: a systematic review and meta-analysis. Anesthesiology. 2014 May;120(5):1080-97. doi: 10.1097/ALN.0000000000000226.

    PMID: 24637618BACKGROUND
  • Soller BR, Yang Y, Soyemi OO, Ryan KL, Rickards CA, Walz JM, Heard SO, Convertino VA. Noninvasively determined muscle oxygen saturation is an early indicator of central hypovolemia in humans. J Appl Physiol (1985). 2008 Feb;104(2):475-81. doi: 10.1152/japplphysiol.00600.2007. Epub 2007 Nov 15.

    PMID: 18006869BACKGROUND
  • Belle A, Ansari S, Spadafore M, Convertino VA, Ward KR, Derksen H, Najarian K. A Signal Processing Approach for Detection of Hemodynamic Instability before Decompensation. PLoS One. 2016 Feb 12;11(2):e0148544. doi: 10.1371/journal.pone.0148544. eCollection 2016.

    PMID: 26871715BACKGROUND

MeSH Terms

Conditions

HemorrhageShock, HemorrhagicAccidental Injuries

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsShockWounds and Injuries

Results Point of Contact

Title
Norman A. Paradis
Organization
Dartmouth Health

Study Officials

  • Noman Paradis, MD

    Dartmouth-Hitchcock Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2021

First Posted

June 3, 2021

Study Start

December 8, 2022

Primary Completion

December 8, 2022

Study Completion

December 8, 2022

Last Updated

May 24, 2024

Results First Posted

May 24, 2024

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

At this time, there are no plans to share IPD.

Locations